Active Pharmaceutical Ingredients* (API)

Sr.No. Product Name CAS No. End Application Specification
1 Moxifloxacin Hydrochloride 354812-41-2 Anti-Bacterial IP/BP/EP/USP/IH
2 Milnacipran Hydrochloride 101152-94-7 Anti-depressant IH
3 Safinamide 133865-89-1 Anti-Parkinson IH
4 Levo-Milnacipran 175131-60-9 Anti-depressant IH
5 Agomelatine 138112-76-2 Anti-depressant IP
6 Gliclazide 21187-98-4 Anti-diabetic IP/BP/EP

*Patent Infringement is the responsibility of the buyers & the products are not offered in countries where a valid patent exists.

Drug Intermediates*

Sr.No. Name CAS No.
Milnacipran Intermediate
1 Cis(±)-1-phenyl-2-oxo-3-oxa bicyclo[3.1.0]hexane (Racemate) [LACTONE] 63106-93-4
2 (1S,5R)-1-phenyl-2-oxo-3-oxa bicyclo[3.1.0]hexane [LEVO LACTONE] 96847-53-9
Lercanidipine Intermediates
1 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitro phenyl)-1,4-dihydropyridine-3-carboxylic acid(Also used in Benidipine) [LRCII] 74936-72-4
2 2,N-Dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol [LRD] 100442-33-9
3 N-Methyl-3,3-Diphenylpropylamine Hydrochloride [MDA.HCL] 28075-29-8
4 3,3-Diphenyl propyl amine[DPA] 5586-73-2
Sevelamer Carbonate
1 2,2’-Azobis[2-methyl-N -(2-hydroxyethyl) propanamide / Water Soluble Azo Inhibitor/polymerization initiator.[VA086] 61551-69-7
Agomelatine Intermediates
1 2-(7-methoxy naphthalen-1-yl)ethanamine 138113-09-4
2 2-(7-methoxy naphthalen-1-yl)acetonitrile 138113-08-3
Safinamide Intermediates
1 (2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl] methylamino]propanamideMesylate (API) 202825-46-5
2 4-(3-Fluoro-benzyloxy) benzaldehyde /td> 66742-57-2
Linagliptine Intermediate
1 2-(chloromethyl)-4-methylquinazoline [CMQ] 109113-72-6
Specialty Chemicals
1 2-5-Dimethyl pyrrole 625-84-3

Under Development*

Sr.No. Product Name CAS No.
1 Nifedipine 21829-25-4
2 7-(4-chlorobutoxy)-1H-quinolin-2-one( Brexpiprazole Intermediate-I ) 913613-82-8
3 1-Benzo[b]thien-4-ylpiperazine monohydrochloride(Brexpiprazole Intermediate-II ) 913614-18-3

*Patent Infringement is the responsibility of the buyers & the products are not offered in countries where a valid patent exists.